Document is current
Any future updates will be listed below
-
Authors
Barrett, Susanna E. http://orcid.org/0000-0003-3149-6654
Yin, Song http://orcid.org/0009-0004-8169-9913
Jordan, Peter
Brunson, John K.
Gordon-Nunez, Jessica http://orcid.org/0009-0003-0365-427X
Costa Machado da Cruz, Gabriella
Rosario, Christopher
Okada, Bethany K.
Anderson, Kelsey
Pires, Thomas A.
Wang, Ruoyang
Shukla, Diwakar http://orcid.org/0000-0003-4079-5381
Burk, Mark J. http://orcid.org/0000-0002-2045-2691
Mitchell, Douglas A. http://orcid.org/0000-0002-9564-0953
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM123998, R35GM142745, R35GM142745)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R21AI167693)
National Science Foundation (DGE 21-46756)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 29 March 2024
Accepted: 12 August 2024
First Online: 11 September 2024
Competing interests
: M.J.B. and D.A.M. are co-founders of and own stock in Lassogen, Inc. S.E.B. and D.A.M. are inventors on a provisional patent application filed by the University of Illinois at Urbana-Champaign covering lasso cyclase engineering (US Provisional Application Ser. No. 63/673,853). M.J.B., P.A.J. and G.C.M.d.C. are inventors on a provisional patent application filed by Lassogen, Inc. for the design of lasso peptide integrin binders (US Provisional Application No. 63/612,957). The other authors declare no competing interests.
